LED Medical Diagnostics Inc.

LED Medical Diagnostics Inc.

June 12, 2012 09:30 ET

VELscope Vx System Named "Best of Class" by Pride Institute

One of Few Products to Ever Win This Prestigious Honor for Two Consecutive Years

BURNABY, BRITISH COLUMBIA--(Marketwire - June 12, 2012) - LED Medical Diagnostics Inc. (TSX VENTURE:LMD) -

Now in its fourth year, the Pride Institute's Best of Class Technology Award continues to recognize products that demonstrate excellence in their category. In 2012, the VELscope Vx enhanced oral assessment device from LED Dental is one of those lauded as "Best of Class".

"To be one of only 18 honorees chosen from the thousands of high quality products available in the dental industry is extremely gratifying," said Peter Whitehead, founder and CEO of LED Dental and its parent, LED Medical Diagnostics Inc. (TSX VENTURE:LMD). "And for the VELscope Vx to be one of only five products to receive this honor for two consecutive years is a testament to the ability of our technology to help dental professionals enhance the health of both their patients and their practices." Exclusively distributed in the U.S. and Canada by Henry Schein, Inc. (NASDAQ:HSID), the handheld device is the world's leading system for early detection of oral cancer and other oral disease.

A panel, composed of leading voices in dental technology, comes together each year to discuss, debate and decide what products merit recognition. Organized by Dr. Lou Shuman, President of Pride Institute, the panel is committed to a selection method that is unbiased and rigorous. While panelists who receive compensation from dental companies are allowed to advocate for products those companies manufacture, they are prevented from voting for those technologies. This facilitates a dynamic process that, year-to-year, honors products both obscure and well-known, basic and aspirational.

"The technology space has exploded in terms of quantity and quality of available products," said Dr. Lou Shuman, DMD, CAGS, President of Pride Institute. "With the potential for a considerable investment amount, it was important that someone step up and provide the corporate and dental communities with an unbiased selection process, led by technology key opinion leadership, with the sole focus of providing true guidance. That was the vision and it has come to fruition thanks to the support of the panel, ADA, Dental Products Report, and Dental Economics."

The panel consists of seven dentists with significant knowledge of and experience in dental technology, including Dr. Shuman; John Flucke, DDS, writer, speaker and Technology Editor for Dental Products Report; Paul Feuerstein, DMD, writer, speaker and Technology Editor for Dental Economics; Titus Schleyer, DMD, PhD, Associate Professor and Director, Center for Dental Informatics at the University of Pittsburg, School of Dental Medicine; Marty Jablow, DMD, author, speaker, technology consultant, and columnist for DrBicuspid.com; Parag Kachalia, DDS, Director of New Technology at the University of the Pacific, School of Dentistry; and Larry Emmott, DDS, technology writer, speaker and dental marketing consultant.

"I feel very fortunate that a panel of this magnitude has agreed to contribute to the selection process," said Dr. Shuman.

The VELscope Vx is the most powerful FDA- and Health Canada-approved tool to screen for oral cancer, a growing health-care issue around the world. It is used by dentists to detect early stage oral cancer and pre-cancer, as well as other oral abnormalities such as viral, fungal and bacterial infections that might otherwise go unseen. The technology is the first to offer both cordless convenience and an optional digital camera and customized bracket that make it easy for dentists to photo-document suspicious lesions.

The Pride Institute Best of Class Technology awards were launched in 2009 as a new concept to provide an unbiased, non-profit assessment of available technologies in the dental space. Through print and digital media coverage, the "Best of Class" message reaches the community of 150,000 dentists through multiple touchpoints-in print and online-educating them about the products. Honoree participation in the "Tech Expo" at the American Dental Association's Annual Session offers face-to-face interaction with the companies as well as technology-centered education provided by members of the panel as well as the esteemed consultants of Pride Institute. Courses at last year's 2011 meeting sold out. This year's event will be held October 18-21 in San Francisco.

About LED Medical Diagnostics Inc.

LED Medical Diagnostics Inc. was founded in 2003 and is headquartered in Burnaby, British Columbia, Canada. Its wholly-owned subsidiary, LED Dental Inc., is the manufacturer of the Velscope Vx enhanced oral assessment system. VELscope Vx devices, the first to apply tissue fluorescence visualization technology to the oral cavity, are used to conduct more screenings for oral cancer and other oral diseases than any adjunctive device in the world. For more information, call +1 (604) 434-4614, or visit www.velscope.com.

About the VELscope Vx

The Velscope Vx is a powerful FDA- and Health Canada-approved tool used to screen for oral cancer. It saves lives by helping detect early stage oral cancer and pre-cancer and other abnormalities in the mouth such as viral, fungal and bacterial infections. The Velscope Vx is exclusively distributed in the U.S. and Canada through a partnership with Henry Schein, the world's largest dental distribution company, and is distributed in more than 20 other countries as well. For more information please call +1 (604) 434-4614, or visit www.velscope.com.

Contact Information